Cargando…
Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects
Bioenergetics and bioenergetic-related functions are altered in Alzheimer's disease (AD) subjects. These alterations represent therapeutic targets and provide an underlying rationale for modifying brain bioenergetics in AD-affected persons. Preclinical studies in cultured cells and mice found t...
Autores principales: | Swerdlow, Russell H., Bothwell, Rebecca, Hutfles, Lewis, Burns, Jeffrey M., Reed, Gregory A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816034/ https://www.ncbi.nlm.nih.gov/pubmed/27051598 http://dx.doi.org/10.1016/j.bbacli.2016.03.005 |
Ejemplares similares
-
Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration
por: Raoufinia, Arash, et al.
Publicado: (2017) -
Pharmacokinetic Interaction Between Isavuconazole and a Fixed‐Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects
por: Yamazaki, Takao, et al.
Publicado: (2016) -
Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia
por: Pérez-Mato, M, et al.
Publicado: (2014) -
Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
por: Scoble, Patrick J., et al.
Publicado: (2015) -
The PEP-pyruvate-oxaloacetate node: variation at the heart of metabolism
por: Koendjbiharie, Jeroen G, et al.
Publicado: (2020)